Ipamorelin is a synthetic growth hormone-releasing peptide (GHRP) widely studied for its selective ability to stimulate endogenous growth hormone (GH) secretion. By acting as a highly selective agonist of the growth hormone secretagogue receptor (GHSR-1a), Ipamorelin has become an important research compound for investigating endocrine regulation, growth hormone physiology, and metabolic function. Unlike some other growth hormone secretagogues, it is recognized in laboratory research for promoting GH release with minimal effects on appetite regulation and cortisol secretion.
Scientific studies have explored Ipamorelin for its influence on growth hormone and insulin-like growth factor-1 (IGF-1) signaling, protein synthesis, muscle physiology, tissue repair, and metabolic regulation. Researchers also investigate its role in supporting muscle recovery, bone metabolism, cellular regeneration, and healthy aging through the study of endocrine and regenerative pathways. Its receptor selectivity makes it a valuable tool for laboratory research focused on growth hormone dynamics, metabolic health, and tissue maintenance.
The formulation provides researchers with a convenient concentration for laboratory investigations into endocrine function, growth hormone biology, regenerative science, muscle physiology, and cellular recovery. Ipamorelin remains an important research peptide for advancing scientific understanding of hormone regulation and metabolic processes.
For research use only. Not intended for human consumption or therapeutic use.
Reviews
There are no reviews yet.